CONTACT US
PanCAN’s evaluation of the Research Grants Program entails systematically examining the grantees’ success in generating additional funding for pancreatic cancer research, publishing their findings in peer-reviewed scientific journals and having their research cited in other publications. All of these achievements help further scientific knowledge on pancreatic cancer.
Our evaluation entails systematically examining our grantees’ success in generating additional funding for pancreatic cancer research, publishing their findings in peer-reviewed scientific journals and having their research cited in other publications. All of these achievements help further scientific knowledge on pancreatic cancer.
For every $1 PanCAN invested through its Research Grants Program from 2003-2024, grant recipients went on to receive an additional $11 in subsequent pancreatic cancer research funding. This tremendous return on investment allows the researchers to continue building on their findings and training young scientists to bring forth future discoveries.
The 217 grantees we evaluated have authored 3,871 scientific publications thus far. Those publications were cited 328,432 times in other papers published in biomedical journals, which means other researchers are reading, learning from and building upon our grantees’ work.
In addition to receiving financial support for their research projects, grantees participate in the organization’s Community for Progress, which provides connections and mentorships with leading scientists in the field. Ongoing career support activities offer opportunities for training, information exchange, collaborations and other professional development activities to help keep the pancreatic cancer community of researchers committed and involved. Our grantees have routinely expressed that inclusion in our Community for Progress is highly beneficial to their careers and research programs.
Since the initiation of the Research Grants Program in 2003, PanCAN has awarded 240 grants to 220 scientists at 78 institutions, with a total research investment of approximately $249 million, including our competitive Research Grants Program and leading-edge scientific and clinical initiatives.
It is important to us to ensure sound stewardship of our research grant investment and provide a measure of accountability to our constituents. The results of this most recent evaluation show that our grant recipients are growing the field of pancreatic cancer research exponentially and moving us ever closer to meeting our goal of improving patient outcomes.
